Intermittent fasting resolves dyslipidemia and atherogenesis in apolipoprotein e-deficient mice in a diet-dependent manner, irrespective of sex

HIGHLIGHTS

• who: Jules Mu00e9rian and collaborators from the Institut des Maladies Mu00e9taboliques et Cardiovasculaires, I MC, Universitu00e9 de Toulouse, Inserm, Universitu00e9 Toulouse III-Paul Sabatier (UPS), UMR1297, Toulouse, France have published the research: Intermittent Fasting Resolves Dyslipidemia and Atherogenesis in Apolipoprotein E-Deficient Mice in a Diet-Dependent Manner, Irrespective of Sex, in the Journal: Cells 2022, 11, x FOR PEER REVIEW of /2022/
• what: This study assessed the metabolic and atheroprotective effects of intervention (IF) in atherosclerosis-prone apolipoprotein E-deficient (Apoe-/- ) mice. In this context, this study aimed to examine whether an IF intervention . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.